Related Experiment Video
Updated: Jul 12, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
NCCN Guideline Concordance Improves Survival in Pediatric and Young Adult Rectal Cancer
Colleen P Nofi1, Sara Siskind2, Gary B Deutsch3
1Cohen Children's Medical Center, Division of Pediatric General, Thoracic, and Endoscopic Surgery, 269-01 76th Avenue, Queens NY 11040, USA; Northwell North Shore/Long Island Jewish, Department of Surgery, 300 Community Drive, Manhasset NY 11030, USA.
Insights
Management guidelines for pediatric and young adult rectal cancer are lacking. Adhering to National Comprehensive Cancer Network (NCCN) guidelines for rectal cancer improves survival in these young patients.
Area of Science:
- Oncology
- Clinical Research
- Cancer Management
Background:
- No established management guidelines exist for pediatric and young adult rectal cancer.
- Adult rectal cancer management guidelines are well-documented, but a gap exists for younger populations.
Purpose of the Study:
- To evaluate the adherence to National Comprehensive Cancer Network (NCCN) guidelines in pediatric and young adult rectal cancer patients.
- To assess the impact of guideline-concordant therapy on survival outcomes in these patient groups.
Main Methods:
- Retrospective analysis of the National Cancer Database (2004-2018).
- Inclusion of pediatric (0-21 years) and young adult (22-40 years) patients diagnosed with rectal cancer.
- Evaluation of pre-operative and post-operative guideline concordance and its correlation with survival using Cox regression and Kaplan-Meier analysis.
Main Results:
- 89.6% of pediatric and 84.6% of young adult patients received pre-operative guideline-concordant therapy.
- Pediatric patients were less likely to receive post-operative guideline-concordant therapy compared to young adults (65.3% vs. 76.7%).
- Guideline-concordant therapy significantly reduced the risk of death in both pediatric and young adult rectal cancer patients.
Conclusions:
- National Comprehensive Cancer Network (NCCN)-based guidelines can effectively guide peri-operative management and enhance survival in pediatric and young adult rectal cancer.
- Due to the rarity of rectal cancer in young patients, a multidisciplinary team approach and patient/family involvement are crucial for optimal treatment strategies.
Background:
Although management guidelines in adult rectal cancer are widely studied, no consensus guidelines exist for the management of pediatric and young adult rectal cancer.
Methods:
The National Cancer Database (2004-2018) was queried for pediatric (age 0-21) and young adult (age 22-40) patients with rectal cancer. Patients were analyzed for receipt of National Comprehensive Cancer Network (NCCN) guideline-concordant therapy. Impact on survival was evaluated using Cox regression and Kaplan-Meier analysis.
Results:
6655 patients (108 pediatric and 6547 young adult patients) with rectal cancer were included. Similar to previously published NCCN quality measures with overall guideline concordance approaching 90 % in adults, 89.6 % of pediatric and 84.6 % of young adult patients were classified as receiving pre-operative guideline-concordant therapy. However, pediatric patients were significantly less likely to receive post-operative guideline-concordant therapy than young adult patients (65.3 % verse 76.7 %, respectively, p = 0.008). Risk of death was significantly lower for pediatric patients who received post-operative guideline-concordant therapy (HR, 0.313; CI, 0.168-0.581; p < 0.001). In young adult patients, risk of death was significantly lower for those who received pre-operative guideline-concordant therapy (HR, 0.376, CI 0.338-0.417, p < 0.001), and post-operative guideline-concordant therapy (HR, 0.456; CI 0.413-0.505; p < 0.001).
Discussion:
NCCN-based guidelines may reasonably guide peri-operative management decisions and improve survival in pediatric and young adult rectal cancer. Given the rarity of this cancer in young patients, employment of an experienced surgical and oncologic multidisciplinary team, along with discussion and involvement of the patient and family, are keys for balancing risks and benefits to offering the best therapeutic strategy.
Type Of Study:
Retrospective.
Level Of Evidence:
Level III.
Related Concept Videos
Cancer Survival Analysis
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...

